Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Symphony Technology consortium $2.075 billion acquisition of RSA from Dell
Davis Polk is advising a consortium led by Symphony Technology Group on its approximately $2.075 billion acquisition of RSA…
TFI International $230 million U.S. IPO
Davis Polk advised the lead book-running managers in connection with the initial U.S. public offering of 6,000,000 common…
Cogna Educação R$2.6 billion equity offering
Davis Polk advised Cogna Educação S.A. in connection with its equity offering of 232,358,004 common shares for an aggregate…
Toyota Motor Credit $2.5 billion notes offering, including green bonds
Davis Polk advised Toyota Motor Credit Corporation in connection with an SEC-registered offering of $1.10 billion aggregate…
Shockwave Medical $16.5 million supplemental term loan
Davis Polk advised Shockwave Medical, Inc. in connection with a $16.5 million supplemental term loan provided by Silicon…
eBay $3 billion accelerated share repurchase
Davis Polk advised counterparties to accelerated share repurchase transactions with eBay Inc., pursuant to which…
Theravance Biopharma $148.5 million follow-on offering
Davis Polk advised the underwriters in connection with the $148.5 million public offering of ordinary shares by…
Revance Therapeutics $287.5 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Revance Therapeutics, Inc. of $287.5…
Revance Therapeutics $287.5 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Revance Therapeutics, Inc. of $287.5…
Moura Dubeux R$1.1 billion IPO
Davis Polk advised the joint bookrunners and the financial adviser in connection with the initial public offering…